GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp IV (NAS:ARYD) » Definitions » Shares Outstanding (EOP)

ARYA Sciences Acquisition IV (ARYA Sciences Acquisition IV) Shares Outstanding (EOP) : 7.54 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ARYA Sciences Acquisition IV Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. ARYA Sciences Acquisition IV's shares outstanding for the quarter that ended in Mar. 2024 was 7.54 Mil.

ARYA Sciences Acquisition IV's quarterly shares outstanding declined from Dec. 2023 (7.93 Mil) to Mar. 2024 (7.54 Mil). It means ARYA Sciences Acquisition IV bought back shares from Dec. 2023 to Mar. 2024 .

ARYA Sciences Acquisition IV's annual shares outstanding declined from Dec. 2022 (19.19 Mil) to Dec. 2023 (7.93 Mil). It means ARYA Sciences Acquisition IV bought back shares from Dec. 2022 to Dec. 2023 .


ARYA Sciences Acquisition IV Shares Outstanding (EOP) Historical Data

The historical data trend for ARYA Sciences Acquisition IV's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition IV Shares Outstanding (EOP) Chart

ARYA Sciences Acquisition IV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
16.71 19.19 19.19 7.93

ARYA Sciences Acquisition IV Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.19 7.93 7.93 7.93 7.54

Competitive Comparison of ARYA Sciences Acquisition IV's Shares Outstanding (EOP)

For the Shell Companies subindustry, ARYA Sciences Acquisition IV's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ARYA Sciences Acquisition IV's Shares Outstanding (EOP) Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, ARYA Sciences Acquisition IV's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where ARYA Sciences Acquisition IV's Shares Outstanding (EOP) falls into.



ARYA Sciences Acquisition IV Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


ARYA Sciences Acquisition IV  (NAS:ARYD) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


ARYA Sciences Acquisition IV Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition IV's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


ARYA Sciences Acquisition IV (ARYA Sciences Acquisition IV) Business Description

Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp IV is a blank check company.
Executives
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Leslie Trigg director C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016
Adam Leo Stone director, 10 percent owner, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Thomas Henderson director 421 KIPLING STREET, PALO ALTO CA 94301
Michael Seth Altman director, 10 percent owner, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Iv 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003